Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instru…
What to know about TMO
Thermo Fisher Scientific Inc. is a large Healthcare company with a mixed financial profile. It scores well on size and sentiment, but growth is worth keeping an eye on.
Should you consider TMO?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
Thermo Fisher Scientific Inc. is a large-cap Healthcare company with a mixed overall financial profile — it sits in the upper half of Healthcare stocks (30 of 59).
-
Profitability is roughly average for the S&P 500 — not a standout in either direction.
-
Valuation is in the middle of the pack — neither obviously cheap nor stretched.
-
Growth has been slower than most peers. That's not necessarily a dealbreaker, but it means the investment case rests more on current earnings than future expansion.
-
There is a small dividend (0.00%), but income-focused investors will likely find better yields elsewhere in the market.
-
Volatility is close to the S&P 500 average — typical market swings, nothing unusual.
-
Analyst sentiment is broadly positive and short interest is low — professionals who cover this stock are mostly optimistic about its near-term prospects.
-
This is a mixed picture — real strengths in some areas, but areas that need watching too. Do your homework on the sector before deciding.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how TMO compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 25.53 | Average |
| Forward P/E | 17.05 | Average |
| PEG Ratio | 1.55 | Above avg |
| Price to Sales | 3.82 | Average |
| Price to Book | 3.27 | Average |
| EV/EBITDA | 19.09 | Average |
| Earnings Yield | 3.92% | Average |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 40.93% | Average |
| Operating Margin | 17.89% | Average |
| Net Profit Margin | 15.15% | Above avg |
| Return on Equity | 13.52% | Average |
| Return on Invested Capital | 5.00% | Average |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 6.20% | Average |
| Revenue Growth (3Y CAGR) | -0.27% | Below avg |
| EPS Growth (YoY) | 11.30% | Average |
| Free Cash Flow Growth | -13.40% | Average |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 1.53 | Above avg |
| Debt to Equity | 0.83 | Above avg |
| Interest Coverage | 6.15 | Average |
| Altman Z-Score | 3.39 | Above avg |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | 0.40% | Below avg |
| Payout Ratio | 9.68% | Top 25% |
| Dividend Growth (5Y) | -2.00% | Top 25% |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 3.91% | Average |
| OCF to Sales | 18.34% | Average |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.87 | Above avg |
| Volatility (30-Day) | 34.90% | Average |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 1.26% | Top 25% |
| Avg. Analyst Rating | 1.54 | Top 25% |
| Target Upside % | 28.97% | Top 25% |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 172.66B | Top 25% |
How does TMO compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to TMO — based on their financial profile.